ESR1 and breast cancer: A recent meta-analysis of ~63,000 women with estrogen receptor-positive (ER+) breast cancer reported that primary tumor diameter and nodal status, which are indicators of tumor aggressiveness, were most strongly correlated with the risk of distant recurrence7.